Interviews

Evaluation of the Program for Enhanced Review Transparency & Communication for New Molecular Entity NDAs & Original BLAs in Prescription Drug User Fee Act

OMB: 0910-0746

IC ID: 206912

Documents and Forms
Information Collection (IC) Details

View Information Collection (IC)

Interviews
 
No Unchanged
 
Voluntary
 

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Interview Script FDA PDUFA V Program Evaluation_Post-Action Interview Script-Sponsor_4-22-2013.docx Yes No Printable Only

Health Consumer Health and Safety

 

135 0
   
Private Sector Businesses or other for-profits
 
   0 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 135 0 0 0 0 135
Annual IC Time Burden (Hours) 203 0 0 0 0 203
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
No associated records found
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

© 2024 OMB.report | Privacy Policy